Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 rece...

Proton pump inhibitors and chronic kidney disease risk: a comparative study with histamine-2 receptor antagonists  Nature

Lindsay’s Nails in Chronic Kidney Disease - The New England Journal of Medicine

Lindsay’s Nails in Chronic Kidney Disease  The New England Journal of Medicine

Today's clinical support | Secondary literature database based on the latest evidence【Official】...

Today's clinical support | Secondary literature database based on the latest evidence【Official】  Elsevier

Kidney Stone Market Size, Share, Growth, Analysis, Report, 2034 - Straits Research

Kidney Stone Market Size, Share, Growth, Analysis, Report, 2034  Straits Research

InterWell Health finalizes $2.4B kidney care merger to combine tech, value-based care capabilitie...

InterWell Health finalizes $2.4B kidney care merger to combine tech, value-based care capabilities  Fierce Healthcare

Innovation from within - Boehringer Ingelheim

Innovation from within  Boehringer Ingelheim

-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action ...

-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action  Nature

Genetic loci influencing kidney function and chronic kidney disease - Nature

Genetic loci influencing kidney function and chronic kidney disease  Nature

Translational Medicine & Clinical Pharmacology - Boehringer Ingelheim

Translational Medicine & Clinical Pharmacology  Boehringer Ingelheim

Leadership - Boehringer Ingelheim

Leadership  Boehringer Ingelheim